INTERNATIONAL PATENT: MEDIMMUNE LIMITED FILES APPLICATION FOR "BRONCHIECTASIS TREATMENT"

GENEVA, Dec. 1 -- MEDIMMUNE LIMITED (1 Francis Crick Avenue Cambridge Biomedical CampusCambridgeCambridgeshire CB2 0AA) filed a patent application (PCT/EP2025/063724) for "BRONCHIECTASIS TREATMENT" on May 19, 2025. With publication no. WO/2025/242618, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KELL, Christopher Martin (c/o MedImmune Limited1 Francis Crick AvenueCambridge Biomedical CampusCambridgeCambridgeshire CB2 0AA), PANDYA, Hitesh Champaklal (c/o AstraZeneca UK Limited1 Francis Crick AvenueCambridge Biomedical C...